ArticleAntibiotics (Basel, Switzerland)2021
ESBL-Producing
Article in Antibiotics (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
39 citing papers in PubMed.
- Article
- The Wildlife-Livestock Interface as a Bidirectional Pathway for the Spread of ESBL-ProducingAnimals : an open access journal from MDPI · 2026Review
- Article
- Genomic Characterization of Selected Multidrug-ResistantAnimals : an open access journal from MDPI · 2026Article
- Innovative essential oil formulations for in vitro inhibition of Biofilm-Forming Extended-Spectrum β-Lactamase-Producing Escherichia coli isolated from canine infectious diarrhea.Veterinary research communications · 2025Article
- ESBL-ProducingVeterinary sciences · 2025Article
- Cross-Sectional Study on Zoonotic Bacteria Carriage by Small Ruminants from Portugal's Central Region.Pathogens (Basel, Switzerland) · 2025Article
- Unexplained High Prevalence of ESBL-Antibiotics (Basel, Switzerland) · 2025Article
- Fecal carriage of resistant Escherichia coli in livestock in Algeria: emergence of NDM and OXA-181.BMC microbiology · 2025Article
- Prevalence of ESBL-producingOne health (Amsterdam, Netherlands) · 2025Review
- Ecological and public health dimensions of ESBL-producingVeterinary world · 2025Review
- Risk Factors for ESBL-ProducingVeterinary medicine international · 2025Article
- Fecal Carriage and Risk Factors Associated with Extended-Spectrum β-Lactamase-/AmpC-/Carbapenemase-ProducingAnimals : an open access journal from MDPI · 2024Article
- Conventionally Reared Wallon Meat Lambs Carry Transiently Multi-Drug-ResistantAnimals : an open access journal from MDPI · 2024Article
- Cross-sectional study of antibiotic resistance toVeterinary world · 2024Article
- The Global Rise of ESBL-ProducingAnimals : an open access journal from MDPI · 2024Review
- Genomic epidemiology of third-generation cephalosporin-resistantApplied and environmental microbiology · 2024Article
- Molecular detection of extended-spectrum β-lactamase-producingOpen veterinary journal · 2024Article
- ISMicrobiology spectrum · 2024Article
- Detection of antimicrobial-resistant Enterobacterales in insectivorous bats from Chile.Royal Society open science · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Antibiotic-resistant bacteria of critical importance for global health such as extended-spectrum beta-lactamases-producing (ESBL)-
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.